STREAM: a pragmatic and explanatory trial for MDR-TB treatment

Lancet Infect Dis. 2019 Jun;19(6):575-576. doi: 10.1016/S1473-3099(19)30215-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • Humans
  • Myocardial Infarction*
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents